TIDEZINE.

Abbott Teams Up With Google Health to Sync Blood Sugar Data — But Do Non-Diabetics Actually Need This?

Abbott's prescription-free CGM device Lingo is integrating with Google Health, feeding data into an AI health coach. But doctors and research suggest the real-world benefit of blood sugar monitoring for non-diabetic users remains murky.

Abbott Teams Up With Google Health to Sync Blood Sugar Data — But Do Non-Diabetics Actually Need This?

A patch originally designed to monitor blood sugar for non-diabetic adults is now sending its data straight into Google Health's AI coach. Abbott has announced a multi-year partnership with Google Health that will let users of Lingo, its over-the-counter continuous glucose monitor (CGM), view their metabolic data directly in the Google Health app, while Google Health Coach dishes out diet and lifestyle recommendations based on those numbers.

Abbott Teams Up With Google Health to Sync Blood Sugar Data — But Do Non-Diabetics Actually Need This?

The question is whether any of this data actually means anything for the average person. Lingo is explicitly marketed for adults who don't use insulin, and Engadget reported back in 2023 on the trend of non-diabetics jumping on the CGM bandwagon — even then, there wasn't much research backing up the idea that obsessively tracking blood sugar swings offers real benefits to this group. Earlier this year, an article from Johns Hopkins Bloomberg School of Public Health reiterated that the health benefits of CGM for non-diabetics remain fuzzy at best. Sure, it might keep people mindful of what they're eating, nudging them toward better choices — but since a non-diabetic body already regulates most blood sugar fluctuations on its own, fixating on the numbers could backfire, pushing people into unhealthy eating habits just to keep their readings low.

Abbott Teams Up With Google Health to Sync Blood Sugar Data — But Do Non-Diabetics Actually Need This?

The bigger issue might be interpretation. Idrees Mughal, a practicing physician known on TikTok as Dr. Idz, told Engadget that even trained doctors need to cross-reference other data points to make sense of CGM readings. For everyday users, "you don't actually know how to interpret it, so the numbers are essentially useless."

The Abbott-Google partnership also includes a fairly ambitious project: combining continuous glucose data with wearable, lab, and survey data for what's billed as the largest real-world metabolic health study of its kind. The goal is to untangle the relationships between activity, sleep, mental state, and metabolic health in order to deliver more personalized daily advice. That research might genuinely help settle the debate over whether non-diabetics should bother with CGMs at all — but it's just as easy to imagine the findings conveniently pointing toward more people buying Lingo devices or subscribing to Google Health Premium. Either way, before overhauling your diet or health habits based on any of this, talking to your own doctor first is probably still the safer bet.

Related

One Button Photo Spills the Beans: Google Confirms Fitbit Edge Launching October 12
Tech

One Button Photo Spills the Beans: Google Confirms Fitbit Edge Launching October 12

Google posted a close-up shot of a side button along with the caption "10.12.26" on social media, effectively confirming the long-leaked Fitbit Edge name and release date. The new device is positioned to sit between the Fitbit Air and Pixel Watch 5.

Parking a 6,000-Pound Trailer with an iPad: We Spent a Night in the Pebble Flow Electric RV
Tech

Parking a 6,000-Pound Trailer with an iPad: We Spent a Night in the Pebble Flow Electric RV

Engadget's reporter spent a full night living in it, breaking down everything from the auto-hitch feature and electrochromic glass to the 45kWh battery—to find out whether this $159,000 electric trailer really lives up to the futuristic image it projected at CES.

Netflix Drops Trailer for "The Altruists": Anthony Boyle Plays Sam Bankman-Fried in 8-Episode Dramatization of the FTX Collapse
Tech

Netflix Drops Trailer for "The Altruists": Anthony Boyle Plays Sam Bankman-Fried in 8-Episode Dramatization of the FTX Collapse

Netflix has released the trailer for its new series "The Altruists," recreating the relationship between FTX founder Sam Bankman-Fried and Caroline Ellison, along with the company's downfall. It premieres November 19.

Meta Blocks All TikTok Ads — "Standard Business Practice" on the Surface, Child Safety Battle Underneath
Tech

Meta Blocks All TikTok Ads — "Standard Business Practice" on the Surface, Child Safety Battle Underneath

Citing "refusing to promote a competitor is normal business behavior," Meta has announced a ban on ads from TikTok parent company ByteDance across seven countries — timed right after Meta itself paid $1.8 billion to settle a child safety lawsuit.

Anthropic Bans "Prolonged, Gratuitous Abuse" of AI Models in New Policy, Tightens Election Rules Too
Tech

Anthropic Bans "Prolonged, Gratuitous Abuse" of AI Models in New Policy, Tightens Election Rules Too

Anthropic's annual usage policy update adds a clause banning users from subjecting Claude and other models to "prolonged and gratuitous" abuse, while also tightening election-related rules—reigniting debate over whether AI should be treated as a sentient subject.

Amazon's New Alexa Tablets Are Here—12-Inch Pro Uses Corning Etching Tech for a "Paper-Like" Screen
Tech

Amazon's New Alexa Tablets Are Here—12-Inch Pro Uses Corning Etching Tech for a "Paper-Like" Screen

Amazon has launched three Alexa+ tablets in 12-inch, 11-inch, and 8-inch sizes, with the flagship 12 Pro spotlighting its Nanomatte etched display co-developed with Corning. Available in the US, Canada, and Mexico starting October 14, prices start at $230.